U.S. Software Stock News

NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Latest News In Cloud AI - AI Investment Surge Highlights Growth and Challenges

Global investment in artificial intelligence (AI) technology surged to $297 billion in 2024 as enterprise adoption accelerates beyond pilot programs, according to BCC Research's recent report. The significant increase in venture funding, primarily directed towards AI-focused companies, underscores a shift in the industry towards production-scale deployment. U.S. companies dominate private AI investments, highlighting a clear technological leadership, while corporate giants such as Google,...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave Sandboxes Brings AI Execution Layer Closer To Customer Workflows

CoreWeave (NasdaqGS:CRWV) has introduced Sandboxes, a secure execution platform for AI agent training and model evaluation. The new product supports reinforcement learning and large scale evaluation workloads on both customer infrastructure and CoreWeave’s managed cloud service. Sandboxes is available through a partnership with Weights & Biases, targeting teams that need controlled, repeatable environments for advanced AI workflows. For investors tracking AI infrastructure, CoreWeave now...
NYSE:LC
NYSE:LCConsumer Finance

LendingClub’s Happen Bank Rebrand And AI Lending Pivot Might Change The Case For Investing In LC

LendingClub has already begun rebranding as Happen Bank, underscoring its shift from a peer‑to‑peer lender to a technology‑focused bank that serves institutional loan buyers, incorporates AI to automate lending, and moves into home improvement, home equity, and mortgage products. This transformation signals a broader ambition to become a full‑service, digitally oriented bank whose technology and data capabilities underpin an expanded consumer lending offering. Next, we’ll examine how the...
NYSE:LVS
NYSE:LVSHospitality

Assessing Las Vegas Sands (LVS) Valuation As Share Price Weakness Meets Mixed Earnings And Cash Flow Signals

Las Vegas Sands stock snapshot Las Vegas Sands (LVS) has drawn attention after its shares closed at US$50.65, with the stock down over the past day, week, month and past 3 months, despite positive annual revenue and net income growth. See our latest analysis for Las Vegas Sands. The stock’s recent share price weakness, including a 7 day share price return down 5.82% and a year to date share price return down 22.33%, contrasts with a 1 year total shareholder return of 22.60%. This suggests...
NYSE:ARMK
NYSE:ARMKHospitality

Aramark (ARMK) Is Up 17.0% After Nexus AI Data Center Push and Higher Q2 Earnings – What's Changed

Earlier this week, Aramark reported fiscal second-quarter 2026 results showing higher sales of US$4,907.34 million and increased net income of US$101.95 million, while also confirming a quarterly dividend of US$0.1200 per share. At the same time, Aramark launched its Nexus platform for hyperscale AI data centers and expanded its higher-education footprint with the University of Wisconsin–Oshkosh partnership, highlighting how large new contracts and specialized offerings are shaping its...
NasdaqGS:DHC
NasdaqGS:DHCHealth Care REITs

Is Diversified Healthcare Trust’s (DHC) Widening Loss Reshaping Its Healthcare REIT Investment Narrative?

Diversified Healthcare Trust previously reported first-quarter 2026 results showing sales of US$49.25 million and total revenue of US$366.47 million, with net loss widening to US$43.28 million and basic loss per share from continuing operations rising to US$0.18. The combination of lower revenue and a much larger loss compared with a year earlier raises questions about the REIT’s operating momentum and cost structure. We’ll now examine how this weaker quarter, marked by higher losses despite...
NasdaqGS:DOX
NasdaqGS:DOXIT

A Look At Amdocs (DOX) Valuation After Earnings Beat And GenAI aOS Launch

Amdocs (DOX) is back in focus after reporting quarterly revenue and earnings per share ahead of its own guidance, while rolling out its new agentic operating system, aOS, and securing fresh commercial deals. See our latest analysis for Amdocs. Despite the upbeat earnings surprise and fresh GenAI contracts, recent share price momentum has been weak, with the stock down over the past month and year, and multi year total shareholder returns also negative. If Amdocs' GenAI push has you thinking...